Key statistics
On Thursday, Can-Fite Biopharma Ltd (CANF:TLV) closed at 2.60, 4.00% above its 52-week low of 2.50, set on Apr 21, 2024.
52-week range
Open | 2.60 |
---|---|
High | 2.70 |
Low | 2.60 |
Bid | 2.60 |
Offer | 2.70 |
Previous close | 2.70 |
Average volume | 20.68m |
---|---|
Shares outstanding | 1.96bn |
Free float | 1.96bn |
P/E (TTM) | -- |
Market cap | 53.05m ILS |
EPS (TTM) | -0.0176 ILS |
Data delayed at least 20 minutes, as of Sep 26 2024 15:24 BST.
More ▼
- Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis
- Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
- Can-Fite Announces Exercise of Warrants for Approximately $5.0 Million in Gross Proceeds
- Can-Fite Provides Namodenoson Patent Update
- Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
- Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
- Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
- Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
More ▼